(Q38882677)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV drug access initiative – Uganda (English)

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

22 March 2024

main subject

Uganda

0 references

anti-retroviral agent

0 references

0 references

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

22 March 2024

author name string

Robert Downing

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Catherine Sozi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Raymond Mwebaze

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Gideon Rukundo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Samuel Malamba

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Richard Respess

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Kurt Hertogs

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Brendan Larder

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Dorothy Ochola

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jonathan Mermin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Badara Samb

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Eve Lackritz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Paul J. Weidle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14565608

22 March 2024

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

17 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

S39-48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

Resistance to antiretroviral therapy among patients in Uganda

20 December 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire

22 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients

22 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group

22 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults.

22 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing.

22 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe

22 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates

22 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.

22 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe

22 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals

22 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals.

22 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV

22 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

22 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

22 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp

22 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

22 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

22 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

22 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

22 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen.

22 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

A cross-sectional survey of HIV genotype mutations conferring resistance to all nonnucleoside reverse transcriptase inhibitors and related features, at the time of failure of antiretroviral therapy in the real world

22 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy

22 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00002030-200317003-00006

22 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14565608%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference